Bbr Partners, LLC Nurix Therapeutics, Inc. Transaction History
Bbr Partners, LLC
- $1.41 Billion
- Q4 2024
A detailed history of Bbr Partners, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Bbr Partners, LLC holds 20,988 shares of NRIX stock, worth $267,177. This represents 0.03% of its overall portfolio holdings.
Number of Shares
20,988
Previous 20,988
-0.0%
Holding current value
$267,177
Previous $471,000
16.14%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding NRIX
# of Institutions
184Shares Held
67MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$86.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$55.3 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$53.4 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$49.4 Million0.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.01MShares$38.3 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $600M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...